B. Tombal Et Al. , "CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT," EUROPEAN UROLOGY SUPPLEMENTS , vol.10, no.2, pp.335-336, 2011
Tombal, B. Et Al. 2011. CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT. EUROPEAN UROLOGY SUPPLEMENTS , vol.10, no.2 , 335-336.
Tombal, B., Oudard, S., Ozguroglu, M., Hansen, S., Kocak, I., Gravis, G., ... Sartor, A. O.(2011). CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT. EUROPEAN UROLOGY SUPPLEMENTS , vol.10, no.2, 335-336.
Tombal, B. Et Al. "CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT," EUROPEAN UROLOGY SUPPLEMENTS , vol.10, no.2, 335-336, 2011
Tombal, B. Et Al. "CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT." EUROPEAN UROLOGY SUPPLEMENTS , vol.10, no.2, pp.335-336, 2011
Tombal, B. Et Al. (2011) . "CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT." EUROPEAN UROLOGY SUPPLEMENTS , vol.10, no.2, pp.335-336.
@article{article, author={B. Tombal Et Al. }, title={CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT}, journal={EUROPEAN UROLOGY SUPPLEMENTS}, year=2011, pages={335-336} }